4//SEC Filing
Jacobsen John R. 4
Accession 0001209191-23-034096
CIK 0001645569other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 8:11 PM ET
Size
7.7 KB
Accession
0001209191-23-034096
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-06-01$30.31/sh−14,307$433,645→ 151,940 total - Sale
Common Stock
2023-06-01$31.24/sh−4,443$138,799→ 147,497 total
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2022.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
DICE Therapeutics, Inc.
CIK 0001645569
Entity typeother
Related Parties
1- filerCIK 0001880979
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 8:11 PM ET
- Size
- 7.7 KB